Frontlight ResearchEarly access
What researchers published on Ovarian cancer
43,205 papers, newest first.
Showing 160 of 43,205
Length of Ischemic Time Is Critical for Accurate Determination of Homologous Recombination Capacity by Immunofluorescence Staining in Ovarian Cancer Formalin-Fixed Paraffin-Embedded Samples.Archives of pathology & laboratory medicine
Serous Ovarian Carcinoma Presenting With Synchronous Breast Metastasis: A Case Report and Literature Review.Clinical case reports
Cost-effectiveness analysis of HRD testing for patients with advanced ovarian cancer in Italy: an update.Frontiers in oncology
Dynamic changes in peritoneal washing cytology during neoadjuvant chemotherapy are associated with survival in advanced ovarian cancer undergoing interval debulking surgery.Japanese journal of clinical oncology
NOTCH3/JAG1 signaling is associated with immunosuppressive tumor microenvironment features in ovarian cancer: links to nutritional risk, CD163+ macrophages, and CD8+ T cell exclusion.Frontiers in public health
Production, Drug Loading, and Therapeutic Delivery of Macrophage-Engineered Vesicles Via Nitrogen Cavitation.Current protocols
Meta-analysisPrevalence of Pathogenic Variants and Variants of Uncertain Significance in Patients With Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis.Human mutation
Histopathological Subtype and Cancer Stem Cell Marker Expression in Advanced Epithelial Ovarian Cancer: A Two-Year Progression-Free Survival Study.World journal of oncology
Extracellular vesicle-based ovarian cancer score combined with O-RADS ultrasound for preoperative risk stratification of adnexal masses.Journal of nanobiotechnology
Correction: Exploration of propionate metabolism-related genes to predict prognosis and immunotherapy response in ovarian cancer.Journal of ovarian research
Case reportFamilial Ovarian Teratoma With Neural Tissue Expression and Anti-NMDAR Encephalitis.Neurology(R) neuroimmunology & neuroinflammation
Matrix Softness and Fluid Shear Force Act Through TRPV4 to Promote Ovarian Cancer Stemness.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Fibronectin and E-cadherin regulate unique invasive traits of drug-resistant ovarian cancer cells.NPJ systems biology and applications
Assessment of 5-year relative survival among patients with cervical, endometrial, and ovarian cancers in Taizhou, Eastern China: a population-based period analysis.BMC women's health
ReviewTumor-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
Generation of mixed ovarian cancer and fibroblast spheroids by bioprinting.In vitro models
Cross-database thromboembolic reporting signals for ovarian cancer therapies: a focus on bevacizumab.BMC cancer
[Emphasis on the standardization of initial treatment for ovarian cancer].Zhonghua yi xue za zhi
ReviewAdvances in Biomarker Discovery for Early Ovarian Cancer Diagnosis.Cells
Diagnostic Performance of Contrast-Enhanced Computed Tomography in Predicting Lymph Node Metastasis in Epithelial Ovarian Cancer: The Added Value of Combining CT with CA-125.Diagnostics (Basel, Switzerland)
Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.International journal of molecular sciences
FABP4 is associated with ROS-dependent ferroptosis inhibition and platinum resistance in ovarian cancer.Tissue & cell
ReviewImmune Resistance and Anti-Tumor Immunity in the Ovarian Tumor Microenvironment.Cells
PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation.iScience
Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies.Cancer
ReviewPrognostic Value of the KELIM Score Versus Conventional CA-125 Kinetics in Ovarian Cancer: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland)
Comparison of Sonidegib and Vismodegib Efficiency in Drug-Sensitive and Resistant Ovarian Cancer Cell Lines-2D and 3D Model Study.International journal of molecular sciences
ReviewThe Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential.International journal of molecular sciences
Multicenter Evaluation of Decentralized Homologous Recombination Deficiency Testing for Enhanced Molecular Diagnosis of Ovarian Cancer.International journal of molecular sciences
A leakage-aware and interpretable machine learning framework for ovarian cancer prediction using the PLCO screening dataset.Frontiers in oncology
Hypoxia-Associated Glycolytic-Lipogenic Reprogramming and Impaired Antigen Presentation in SPP1+ Tumor-Associated Macrophages in Ovarian Cancer.International journal of molecular sciences
Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.International journal of molecular sciences
ReviewFolate Receptor Alpha (FRα/FOLR1) in Cancer: Diagnostic, Prognostic or Predictive Biomarker? A Critical Review of Its Clinical Utility.International journal of molecular sciences
Comparison of Survival Outcomes with First-Line PARP Inhibitor Maintenance According to BRCA Mutation and Homologous Recombination Deficiency Status in Advanced Ovarian Cancer: A Single-Center Retrospective Cohort Study.Cancers
ReviewExtracellular Vesicle-Associated Epithelial-Mesenchymal Plasticity (EMP) as a Driver of Metastatic Evolution and Therapeutic Resistance in Ovarian Cancer.Cancers
Platelet-Derived Extracellular Vesicles for the Diagnosis of Ovarian Cancer.Cancers
"Hearing the Ovarian Cancer Whisper": A Pipeline Program Introducing Medical Students to Gynecologic Oncology, Focusing on the Diagnosis and Management of Ovarian Cancer.Medical science educator
Minimally invasive surgery improves surgical and analgesic outcomes in overweight or obese patients with borderline ovarian tumors: A retrospective cohort study.Medicine
Compartment-Resolved Profiling Identifies Shared Stromal Programs and Clarifies Molecular Subtype Origins in Ovarian Cancer.Cancer research
ReviewCellular senescence in ovarian cancer: context-dependent effects on tumor immunity and therapy response.Frontiers in immunology
Risk Factor Profiles May Differ Between Younger-Onset and Late-Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort.Asia-Pacific journal of clinical oncology
Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer.Cell systems
Clinical characteristics and treatment strategies of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis based on a case series.Frontiers in neurology
Tuberculous Salpingo-Oophoritis Mimicking Ovarian Malignancy: A Case Report of a Diagnostic Dilemma.Clinical case reports
MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer.Molecular therapy. Oncology
Surgical opportunities for primary prevention of high-grade serous ovarian cancer: a procedure-level analysis of opportunistic salpingectomy.Journal of ovarian research
Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway.Archives of biochemistry and biophysics
Trial resultPamiparib plus surufatinib with ctDNA monitoring in platinum-resistant ovarian cancer after PARP inhibitor progression: a phase Ib/II trial (POST-PARPi).BMC medicine
AIF promotes ovarian cancer progression by competitively binding TRAP1 to stabilize MtCK1 to drive phosphocreatine synthesis.Journal of translational medicine
Fertility-sparing surgery for early-stage epithelial ovarian cancer: evolving criteria for patient selection.Japanese journal of clinical oncology
Randomised trialFuzuloparib in combination with apatinib versus fuzuloparib alone for recurrent ovarian cancer: a randomized, open-label, phase 2 trial.Journal of ovarian research
PD-L1 expression in epithelial ovarian cancer and survival: a retrospective cohort study.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
Racial and ethnic differences in ovarian cancer survival across SEER registry states.Gynecologic oncology
ReviewThe hidden genome of high-grade serous ovarian carcinoma: repetitive DNA, extrachromosomal DNA, and complex structural variation.Frontiers in molecular biosciences
The p38α MAPK-MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression.Proceedings of the National Academy of Sciences of the United States of America
Editorial: New horizons in the management of advanced epithelial ovarian cancer.Frontiers in medicine
Epigenetic Divergence Distinguishes Molecularly and Histologically Distinct Subtypes of Small Cell Carcinoma of the Ovary Hypercalcemic Type.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation.Frontiers in cell and developmental biology
A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Deep learning radiomics nomogram based on enhanced CT for differentiating epithelial ovarian borderline tumors and early-stage epithelial ovarian cancers.BMC cancer
Causal effects of genetically predicted CCL25 signaling on ovarian cancer risk: A 2-sample Mendelian randomization study.Medicine
Case reportManagement of an incidentally discovered pancreatic neoplasm mimicking an ovarian neoplasm during pregnancy: A case report.Medicine
Meta-analysisPoly (ADP-ribose) polymerase inhibitors (PARPi) for treating advanced epithelial ovarian cancer.The Cochrane database of systematic reviews
Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1- and BRCA2-associated breast and ovarian cancer.NPJ breast cancer
Selective miRNA network modulation by quinolone derivative CF5 is associated with potent anti-ovarian cancer activity.Bioscience reports
ReviewBEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer.Gynecologic oncology
[Oncogenetics consultation].Annales de chirurgie plastique et esthetique
Considerations on external validation, potential data leakage, and model selection in a PET/CT-based radiomics model predicting residual disease in ovarian cancer.Journal of ovarian research
Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial.The Lancet. Oncology
Identification and Biological Evaluation of Fisetin as a Novel DYRK1B Inhibitor in Ovarian Cancer with Apoptotic and Ferroptotic Effects.Drug design, development and therapy
Prospective Analysis of Breastfeeding History and Ovarian Cancer Risk: Results From the Ovarian Cancer Cohort Consortium.International journal of cancer
Case reportBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
ReviewAdvances in the application of fluorescent probes for ovarian cancer.Journal of ovarian research
Blood-based RNA biomarker for the early detection of ovarian cancer.Nature medicine
Correction: Carboxylesterase 1 is a core metabolic vulnerability of platinum-resistant high-grade serous ovarian carcinoma.Journal of experimental & clinical cancer research : CR
A novel candidate biomarker for detecting premalignant and early ovarian cancer.Nature medicine
ReviewExosomal microRNAs in apoptosis and chemoresistance of ovarian cancer: mechanisms and therapeutic implications.Medical oncology (Northwood, London, England)
Development and Validation of Machine Learning Models Incorporating TGFBIp Expression for Prognosis Prediction in Epithelial Ovarian Cancer.Cancer reports (Hoboken, N.J.)
Synergistic antitumor activity of Napabucasin and Curcumin via ROS accumulation and apoptotic cell death induction in ovarian cancer cells.Molecular biology reports
Association of Preoperative Systemic Inflammation Response Index and Neutrophil-to-Lymphocyte Ratio with Cytoreduction Outcomes in Ovarian Cancer: A Retrospective Cohort Study.International journal of women's health
RAD52 is a therapeutic vulnerability for acquired PARP inhibitor resistance in ovarian cancer.JCI insight
Case reportManagement of a perforated extensive ovarian tumor with radical resection and long-term tumor-free outcome: a case report.Journal of medical case reports
Feasibility of transvaginal ultrasound with endorectal micro-enema for the detection of rectosigmoid anastomotic leakage after cytoreductive surgery for ovarian cancer: preliminary experience from an ambispective single-center study.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
UHRF1 Supports PARP1 Protein Stability and Ovarian Cancer Progression by Limiting PARP1 Polyubiquitination.Cancer science
Corrigendum to "Methods for isolation, detection and characterization of circulating tumor cells in epithelial ovarian carcinoma and summarized evidence of their association with survival outcome: a scoping review" [Crit. Rev. Oncol./Hematol. 227 (2026) 105614].Critical reviews in oncology/hematology
Observational studyPreoperative discrimination of malignant and benign ovarian masses using cfDNA fragmentomics and serum biomarkers.Molecular biomedicine
ReviewThe role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer.Cancer biology & therapy
ReviewIdentification of ovarian cancer cell based on mechanical properties of regional heterogeneity of cells.Biosensors & bioelectronics
ReviewExploring the molecular pathways of Noncoding RNAs in ovarian cancer: insights into treatment resistance.Journal of ovarian research
Fertility and Oncological Outcomes of Ovarian Cancer Patients Treated With Fertility Sparing Surgery.Indian journal of surgical oncology
PAQR5 links microvascular invasion, innate immune inflammatory amplification, and platinum resistance in ovarian cancer.Translational oncology
Comment on "Breast cancer prevention in patients with gBRCA-mutated ovarian cancer".Journal of cancer research and clinical oncology
Case reportMultidisciplinary management of adult-type ovarian granulosa cell tumor in a patient with severe peripheral arterial disease and chronic limb-threatening ischemia: a case report.Journal of medical case reports
Practical application and exploratory prognostic assessment of the FIGO 2023 stage IA3 criteria in endometrioid endometrial cancer with concurrent ovarian tumours.International journal of clinical oncology
Beyond the surgeon's eye: towards a molecular definition of complete cytoreduction in advanced ovarian cancer.Gynecologic oncology
[Corrigendum] CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.Oncology reports
CT-Derived Body Composition Enhances Risk Prediction for Early Progression and Platinum Resistance in High-Grade Serous Ovarian Cancer.Cancer medicine
Response by Wang to "Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts".Journal of gynecologic oncology
Response by One et al. to "Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts".Journal of gynecologic oncology
ReviewThe Tumor Microenvironment of Ovarian Cancer through a Spatial Topological Lens: From Immune Exclusion Mechanisms to Next-Generation Precision Interventions.Critical reviews in oncology/hematology
Progression on PARP versus prior PARP exposure: interpreting subsequent platinum sensitivity in ovarian cancer.Journal of gynecologic oncology
Correction to "Proteomic Studies That Predict Patients' Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review".Journal of proteome research
ReviewTargeting histone methylation with ROS nanoparticles delivering PARPi prodrugs to amplify the stimulation of cGAS-STING for immunotherapy in ovarian cancer.Materials today. Bio
Combined baicalein and the neocryptolepine derivative Z2 enhance anti-ovarian cancer efficacy by inhibiting the CDK4/6-Rb signaling pathway.Toxicology and applied pharmacology
ReviewImmunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations.Oncology research
Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation.Oncology research
Expression, association with clinicopathological features and prognostic potential of FOXR2, mTOR, HIF-1α and PKM2 in high-grade serous carcinoma of the ovary.Diagnostic pathology
ReviewMetabolic Landscape and Immune Microenvironment in Ovarian Cancer: Mechanisms of Remodelling and Therapeutic Opportunities.Immunology
ReviewOvarian Carcinoma: Signal Pathways and Clinical Studies.MedComm
An interpretable machine learning model integrating 54 test indicators and age: a single-center study on precise discrimination between serous ovarian cancer and ovarian cysts.BMC medical informatics and decision making
RPPH1 drives ovarian cancer cells proliferation via CDK9-c-Myc axis.Journal of ovarian research
To interpret gypenoside-L mediated PIWI/piRNA regulatory effect on cuproptosis in ovarian cancer and the mechanism based on PANDORA-seq.Journal of natural medicines
Assessment of genomic instability and homologous recombination repair in ovarian cancer using the Oncomine Comprehensive Assay Plus.Oncotarget
CRIP1 Promotes Ovarian Cancer Progression by Mediating the KRAS-USP7 Interaction and Stabilizing KRAS.Reproductive sciences (Thousand Oaks, Calif.)
Complete Surgical Resection of Rare Solitary Anterior Mediastinal Metastasis From Ovarian Clear Cell Carcinoma.Respirology case reports
Statement of Retraction: Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10).Bioengineered
Corrigendum to "Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients" [J. Pharmaceut. Biomed. Anal. 237 (2024) 115758].Journal of pharmaceutical and biomedical analysis
Retraction notice to "389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study": [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549].Annals of oncology : official journal of the European Society for Medical Oncology
Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses.Journal of biochemical and molecular toxicology
Image-guided photothermal therapy in ovarian cancer using a pH-sensitive ICG/TPZ nanoliposome to overcome thermoresistance.Colloids and surfaces. B, Biointerfaces
The hMOF/PCNA Axis Mitigates Cisplatin Resistance in Ovarian Cancer Cells via Modulating DNA Damage Response.Reproductive sciences (Thousand Oaks, Calif.)
Stromal APOL4 defines a cancer-associated fibroblast state that organizes a chemosensitive niche in ovarian cancer.Experimental & molecular medicine
NFE2L1 promotes cisplatin resistance by attenuating ferroptosis through SLC27A2-mediated fatty acid metabolism in ovarian cancer.Cell death and differentiation
ReviewThe Role of miRNAs in Regulating Cellular Senescence: A Potential Strategy for Overcoming Drug Resistance in Ovarian Cancer.Frontiers in bioscience (Landmark edition)
Trial resultOlaparib plus tremelimumab in women with recurrent ovarian cancer and a germline BRCA1 or BRCA2 mutation: a phase I/II study.Nature communications
In plain wordsRead moreRead the paper on PubMedTargeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer.Cell death & disease
Elevated human epididymis protein 4 levels in chronic kidney disease compromise the accuracy of the risk of ovarian malignancy algorithm.Experimental and therapeutic medicine
In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer.Acta pharmaceutica Sinica. B
Curcumin in ovarian cancer: mechanistic promise and the pharmacokinetic barrier to clinical translation.Natural product research
Repositioning of cis-flupentixol for the suppression of ovarian cancer cell migration and invasion through ERK5 inhibition.Molecular medicine (Cambridge, Mass.)
METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression.Science advances
Economic evaluation alongside the PAOLA-1 /ENGOT-ov25 trial: cost of ovarian cancer and cost-effectiveness of olaparib plus bevacizumab first-line maintenance.Cost effectiveness and resource allocation : C/E
Chemotherapy-refractory high-grade serous ovarian carcinoma: single-cell findings, TCGA-OV transcriptomic context, and a single-case MRI-transcriptome illustration.Frontiers in genetics
ReviewArtificial intelligence assisted genomic profiling of ovarian cancer liver metastases.Frontiers in genetics
Preferential toxicodynamic effects of fenbendazole in ovarian cancer and nonmalignant ovarian cell models.Drug and chemical toxicology
Calcified foraminal metastasis from ovarian low-grade serous carcinoma mimicking a nerve sheath tumor.Skeletal radiology
Application of semidefinite programming approach for detection of genomic copy number variations from peripheral blood in ovarian cancer.Frontiers in oncology
A modified ovarian-adnexal reporting and data system ultrasound for differentiating ovarian carcinoma: integration of the risk of malignancy algorithm into the American College of Radiology's O-RADS US framework.Frontiers in oncology
Patient characteristics and clinical indicators influencing oncologists' perceptions of prognosis in ovarian cancer: a discrete choice experiment.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Poly(adenosine diphosphate-ribose) polymerase-inhibitor response evaluation in recurrent epithelial ovarian cancer using circulating tumor DNA and functional homologous recombination-deficient testing.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Synergistic antitumor effects of combined pembrolizumab and anlotinib via EGFR inhibition and tumor microenvironment remodeling in high-grade serous ovarian cancer.Frontiers in oncology
Longitudinal human epididymis protein 4 kinetics in first-line treatment of advanced ovarian carcinoma: Mathematical modeling and prognostic implications.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Prognostic value of PD-L1 expression and association with HRD in high-grade serous ovarian cancer: an ancillary analysis of the PAOLA-1/ENGOT-ov25 trial (GINECO).ESMO open
Integrative Multi-Model Analysis Identifies a Core Gene Signature Associated with WEE1 Inhibitor Resistance, the Resistance-Associated Tumor Microenvironment, and Therapeutic Vulnerability in Ovarian Cancer.Current cancer drug targets
Concentration-Based Short-Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 Trial.Journal of surgical oncology
T2-weighted MRI-based radiomics for preoperative prediction of homologous recombination deficiency status in high-grade serous ovarian carcinoma.Abdominal radiology (New York)
Case reportPrimary ovarian insular carcinoid in an infertile woman managed with fertility preservation: a case report.BMC women's health
Microfluidic lipid nanoparticles co-delivering siMOB1A and paclitaxel for ovarian cancer therapy.Journal of ovarian research
Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis.Clinical and translational medicine
Meta-analysisPrognostic factors of synchronous endometrial and ovarian cancers: a systematic review and meta-analysis of cohort studies.BMC cancer
In plain wordsRead moreRead the paper on PubMedCT-based adaptation of the Vizzielli laparoscopic risk-adjusted score in advanced ovarian cancer: Agreement and inter-reader reproducibility.European journal of radiology
Fallopian tube cytology combined with p53 and PAX-8 immunocytochemistry in diagnosing ovarian carcinoma: a prospective study.BMC cancer
[Uterine tumor resembling ovarian sex cord tumor: a clinicopathological and molecular analysis of ten cases].Zhonghua bing li xue za zhi = Chinese journal of pathology
Review[Advances and hot topics in the treatment of epithelial ovarian cancer].Zhonghua yi xue za zhi
Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer.Clinical and translational medicine
Near-Infrared Light-Responsive Liposomes for Modulating Switchable CAR-T Cell Therapy.International journal of nanomedicine
Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion.Gynecologic oncology
Clinical outcomes of 5-day administration of topotecan combined with bevacizumab for platinum-resistant ovarian cancer: a multicenter retrospective analysis.International journal of clinical oncology
Mechanical dysfunction: ovarian cancer ascites disables NK cells by suppressing CDC42-driven force generation.Frontiers in immunology
Boosting ovarian cancer immunotherapy via discoidin domain receptor 2 blockade and CD28 x mucin 1 bispecific antibodies.BMC medicine